Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.
D000469:Alkaline Phosphatase / Q000097:blood; D000700:Analgesics / Q000097:blood*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D001219:Aspartate Aminotransferases / Q000097:blood; D001798:Blood Proteins; D002986:Clinical Trials as Topic; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D008297:Male; D051381:Rats; D012709:Serum Albumin / Q000032:analysis; D013844:Thiazoles / Q000097:blood* / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D012709:Serum Albumin; D013844:Thiazoles; D007521:Isocitrate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase